SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-05-010272
Filing Date
2005-11-29
Accepted
2005-11-29 17:01:45
Documents
2
Period of Report
2005-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR AMEX DELIST 2ND NOTICE 112205 amex112205.htm 8-K 25892
2 DOR AMEX PRESS RELEASE 112205 pressrelease112205.htm EX-99.1 17070
  Complete submission text file 0001140361-05-010272.txt   44737
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 051232603
SIC: 2834 Pharmaceutical Preparations